Consultant pharmacist training to shift to PSA and ACP.
The Australian Association of Consultant Pharmacy (AACP) will cease operations at the end of the year, with the organisation’s co-owners to provide separate accreditation programs going forward.
In a joint statement, the Pharmacy Guild of Australia and the Pharmaceutical Society of Australia (PSA) said the decision was made to remove a potential barrier to maintaining and increasing the accredited pharmacist workforce, and to support accredited pharmacists in a rapidly changing professional landscape.
The AACP will continue to assess and offer initial accreditation to candidates, with those due to complete their accreditation before early 2023 able to complete it through the AACP’s program, while pharmacists currently completing Stage 2 have the option to join either the PSA or the Australasian College of Pharmacy’s (ACP’s) programs from 2023.
“We encourage all pharmacists who are undergoing accreditation to continue their accreditation process with the AACP, with further guidance available from the AACP about transition arrangements in the coming weeks,” the organisations said.
“PSA and PGA are committed to supporting all accredited pharmacists.
“Support for accredited pharmacists will be available through PSA and ACP.
“Both organisations are working with AACP and their staff to ensure a seamless transition that offers a high standard of support.”
More details in today’s issue of Pharmacy Daily.
